373 related articles for article (PubMed ID: 32660617)
1. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation.
Pedroza DA; Subramani R; Tiula K; Do A; Rashiraj N; Galvez A; Chatterjee A; Bencomo A; Rivera S; Lakshmanaswamy R
Lab Invest; 2021 Jun; 101(6):733-744. PubMed ID: 33903732
[TBL] [Abstract][Full Text] [Related]
3. S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.
Ahmed IS; Chamberlain C; Craven RJ
Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):361-70. PubMed ID: 22292588
[TBL] [Abstract][Full Text] [Related]
4. High Level of Progesteron Receptor Membrane Component 1 (PGRMC 1) in Tissue of Breast Cancer Patients is Associated with Worse Response to Anthracycline-Based Neoadjuvant Therapy.
Willibald M; Wurster I; Meisner C; Vogel U; Seeger H; Mueck AO; Fehm T; Neubauer H
Horm Metab Res; 2017 Aug; 49(8):595-603. PubMed ID: 28701017
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
Friel AM; Zhang L; Pru CA; Clark NC; McCallum ML; Blok LJ; Shioda T; Peluso JJ; Rueda BR; Pru JK
Cancer Lett; 2015 Jan; 356(2 Pt B):434-42. PubMed ID: 25304370
[TBL] [Abstract][Full Text] [Related]
7. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.
Clark NC; Friel AM; Pru CA; Zhang L; Shioda T; Rueda BR; Peluso JJ; Pru JK
Cancer Biol Ther; 2016; 17(3):262-71. PubMed ID: 26785864
[TBL] [Abstract][Full Text] [Related]
9. PGRMC1: a new biomarker for the estrogen receptor in breast cancer.
Craven RJ
Breast Cancer Res; 2008; 10(6):113. PubMed ID: 19090968
[TBL] [Abstract][Full Text] [Related]
10. May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?
Zhang Y; Ruan X; Willibald M; Seeger H; Fehm T; Neubauer H; Mueck AO
Gynecol Endocrinol; 2016; 32(1):58-60. PubMed ID: 26303031
[TBL] [Abstract][Full Text] [Related]
11. PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study.
Cai G; Ruan X; Gu M; Zhao Y; Wang Y; Mueck AO
Gynecol Endocrinol; 2020 Nov; 36(11):1024-1027. PubMed ID: 32208774
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling.
Pedroza DA; Rajamanickam V; Subramani R; Bencomo A; Galvez A; Lakshmanaswamy R
Br J Cancer; 2020 Oct; 123(8):1326-1335. PubMed ID: 32704174
[TBL] [Abstract][Full Text] [Related]
13. Absence of progesterone receptor membrane component 1 reduces migration and metastasis of breast cancer.
Lee SR; Lee YH; Jo SL; Heo JH; Kim G; Lee GS; An BS; Baek IJ; Hong EJ
Cell Commun Signal; 2021 Apr; 19(1):42. PubMed ID: 33832499
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer.
Ruan X; Zhang Y; Mueck AO; Willibald M; Seeger H; Fehm T; Brucker S; Neubauer H
Menopause; 2017 Feb; 24(2):203-209. PubMed ID: 27749742
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging.
Causey MW; Huston LJ; Harold DM; Charaba CJ; Ippolito DL; Hoffer ZS; Brown TA; Stallings JD
J Surg Res; 2011 Dec; 171(2):615-22. PubMed ID: 20655063
[TBL] [Abstract][Full Text] [Related]
16. The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model.
Zhao Y; Ruan X; Wang H; Li X; Gu M; Wang L; Li Y; Seeger H; Mueck AO
Maturitas; 2017 Aug; 102():26-33. PubMed ID: 28610679
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
[TBL] [Abstract][Full Text] [Related]
19. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Mir SU; Ahmed IS; Arnold S; Craven RJ
Int J Cancer; 2012 Jul; 131(2):E1-9. PubMed ID: 21918976
[TBL] [Abstract][Full Text] [Related]
20. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
